KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Other Non-Current Assets (2016 - 2020)

Abbott Laboratories' Other Non-Current Assets history spans 12 years, with the latest figure at $824.0 million for Q4 2020.

  • On a quarterly basis, Other Non-Current Assets rose 19.94% to $824.0 million in Q4 2020 year-over-year; TTM through Dec 2020 was $824.0 million, a 19.94% increase, with the full-year FY2020 number at $824.0 million, up 19.94% from a year prior.
  • Other Non-Current Assets hit $824.0 million in Q4 2020 for Abbott Laboratories, up from $687.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for ABT hit a ceiling of $2.8 billion in Q4 2016 and a floor of $2.0 million in Q1 2016.
  • Historically, Other Non-Current Assets has averaged $647.2 million across 5 years, with a median of $148.5 million in 2017.
  • Biggest five-year swings in Other Non-Current Assets: soared 2521.9% in 2016 and later crashed 97.74% in 2017.
  • Tracing ABT's Other Non-Current Assets over 5 years: stood at $2.8 billion in 2016, then plummeted by 93.61% to $176.0 million in 2017, then skyrocketed by 231.25% to $583.0 million in 2018, then increased by 17.84% to $687.0 million in 2019, then rose by 19.94% to $824.0 million in 2020.
  • Business Quant data shows Other Non-Current Assets for ABT at $824.0 million in Q4 2020, $687.0 million in Q4 2019, and $583.0 million in Q4 2018.